1. Home
  2. SBFM vs CPHI Comparison

SBFM vs CPHI Comparison

Compare SBFM & CPHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sunshine Biopharma Inc.

SBFM

Sunshine Biopharma Inc.

HOLD

Current Price

$1.15

Market Cap

6.0M

Sector

Health Care

ML Signal

HOLD

Logo China Pharma Holdings Inc.

CPHI

China Pharma Holdings Inc.

N/A

Current Price

$0.60

Market Cap

6.1M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
SBFM
CPHI
Founded
2006
N/A
Country
United States
China
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.0M
6.1M
IPO Year
N/A
2008

Fundamental Metrics

Financial Performance
Metric
SBFM
CPHI
Price
$1.15
$0.60
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$7.00
N/A
AVG Volume (30 Days)
35.0K
12.7K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
70.33
EPS
N/A
N/A
Revenue
N/A
$4,528,929.00
Revenue This Year
$10.26
N/A
Revenue Next Year
$32.63
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.05
$0.12
52 Week High
$3.90
$14.00

Technical Indicators

Market Signals
Indicator
SBFM
CPHI
Relative Strength Index (RSI) 40.60 36.73
Support Level N/A N/A
Resistance Level $1.52 $1.88
Average True Range (ATR) 0.05 0.05
MACD -0.00 0.03
Stochastic Oscillator 30.00 68.14

Price Performance

Historical Comparison
SBFM
CPHI

About SBFM Sunshine Biopharma Inc.

Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. Through its subsidiaries, the company has various generic prescription drugs on the market in Canada and is also involved in developing and selling OTC supplements. In addition, the company is conducting a proprietary drug development program, which is comprised of K1.1 mRNA targeted for liver cancer and SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections.

About CPHI China Pharma Holdings Inc.

China Pharma Holding Inc is a drug manufacturing company. It is mainly engaged in the development, manufacture, and marketing of pharmaceutical products for human use in connection with a variety of high-incidence and high-mortality diseases and medical conditions prevalent in the People's Republic of China. The company mainly manufactures pharmaceutical products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. The product line of the company includes cefaclor dispersible tablets, clarithromycin granules, roxithromycin dispersible tablets, andrographolide tablets, ozagrel sodium for injection, gastrodin injection and others.

Share on Social Networks: